Alantra advised Spectris, a productivity-enhancing instrumentation and controls company, on its acquisition of Concept Life Sciences from Equistone Partners Europe and company management.

Jan 2018

Buy-side advisory

Alantra, has advised Spectris plc, the productivity-enhancing instrumentation and controls company, on its acquisition of Concept Life Sciences from Equistone Partners Europe and company management.

Concept Life Sciences is a UK-based group providing integrated drug discovery, development, analytical testing and environmental consultancy services to an international customer base, mainly in the pharmaceutical, biotechnology, agrochemical and environmental sectors. Additionally, it carries out development and analytical services for the food, consumer and environmental industries.

This acquisition adds test service capabilities to Spectris’ Materials Analysis segment, where it has strong synergies with the activities of Malvern Panalytical, especially in the pharmaceutical, biopharmaceutical and agrochemical markets. These markets are expected to continue to grow as a result of increasing regulation, the complexity of pharmaceutical R&D and investments in new therapies, particularly protein-based pharmaceuticals.